Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|September 26, 1997
Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIIIM Swaroop, M Moussalli, S W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
New high-technology products for the treatment of haemophiliaS W Pipe, J-M Saint-Remy, C E Walsh
Journal of Thrombosis and Haemostasis : JTH|April 27, 2007
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatmentG F Pierce, D Lillicrap, S W Pipe, et al.
Thrombosis and Haemostasis|November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albuminH J Metzner, S W Pipe, T Weimer, et al.
The Journal of Biological Chemistry|April 15, 1994
A role for the C2 domain of factor VIII in binding to von Willebrand factorE L Saenko, M Shima, K J Rajalakshmi, et al.
The Journal of Biological Chemistry|May 9, 1998
Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulinS W Pipe, J A Morris, J Shah, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2011
Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotypingK Ogata, S R Selvaraj, H Z Miao, et al.
Trends in Cardiovascular Medicine|October 24, 2001
Catabolism of the coagulation factor VIII: can we prolong lifetime of f VIII in circulation?N M Ananyeva, D V Kouiavskaia, M Shima, et al.
Pageof 9